Jakarra J. Jones


Related Content

  • Samford University, Cumberland School of Law, JD, cum laude, Associate Editor, Law Review, 2007
  • Georgia Institute of Technology, BS, Industrial Engineering, President’s Scholar, 2004
  • District of Columbia
  • Georgia
  • Virginia
  • U.S. Court of Appeals for the 4th Circuit

JJ enjoys a decade of experience in complex civil litigation, as well as conducting confidential investigations, compliance counseling and responding to government investigations, prosecutions and civil enforcement proceedings.  She offers expertise in the life sciences, healthcare and financial services sectors.

Before rejoining the firm in 2016, JJ served as a Civil Division Assistant United States Attorney (AUSA), successfully defending the United States in over 100 federal civil cases and investigating and prosecuting healthcare fraud, including parallel civil-criminal proceedings, and wage and hour fraud.  She also provided timely advice, early case assessment, and efficient litigation and risk management strategies to federal agencies’ legal departments, including the lawyers for the Departments of Commerce, HHS, Homeland Security, HUD and Education, as well as the SSA, IRS, USPS and Maryland’s federally-qualified community health centers. 

JJ successfully defended federal agencies in litigation concerning complex torts, employment discrimination, judicial review of agency actions, immigration, and challenges to federal programs, as well as student loan discharge and mortgagors’ rights in bankruptcy proceedings.  JJ independently managed her continuous caseload of 35-45 active matters from pre-discovery dispositive motions through trial or settlement and Fourth Circuit appeals.

As a defense attorney and federal prosecutor, JJ has gained a unique depth and breadth of first-chair internal and external investigation experience, including implementing investigation plans, efficiently managing e-discovery and document reviews, interviewing witnesses, drafting investigation reports and presenting findings to senior executives, regulators and prosecutors.  As defense counsel, JJ has assisted Fortune 250 companies in several of the most significant healthcare fraud and FCPA cases of the past decade.  She has also assisted financial services companies and public accounting firms in a number of auditing and financial disclosure and reporting matters before the PCAOB and SEC.

Jakarra J Jones
T: +1 804 775 1132F: +1 804 698 2054Gateway Plaza
800 East Canal Street
Richmond, VA 23219-3916

Jana Cantrel v. United States (D. Md. 2015). Lead counsel for the United States in this medical malpractice case alleging negligence and negligent/intentional infliction of emotional distress. Obtained complete defense victory in bench trial.

Adote Akwei v. Sylvia Burwell (D. Md. 2016). Lead counsel for U.S. Department of Health and Human Services in this employment discrimination, wrongful termination and harassment case brought under Title VII by National Institutes of Health employee; obtained complete summary judgment in favor of defendant.

Yasmin Atkins v. Sylvia Burwell (D. Md. 2016). Lead counsel for U.S. Department of Health and Human Services in this sexual harassment case brought by government contractor; obtained complete summary judgment in favor of defendant.

Marguerite Edwards v. Thomas Vilsack (D. Md. 2016). Lead counsel for U.S. Department of Agriculture in this case alleging age-based discrimination in violation of ADEA and race-based discrimination in violation of Title VII; obtained complete summary judgment in favor of defendant.

Monica Stitt v. U.S. Dep’t of Education (D. Md. 2015). Lead defense counsel for U.S. in this bankruptcy adversary proceeding where plaintiff sought to obtain student loan discharge; obtained complete defense victory in bench trial; successfully defended against multiple appeals.

Defended pharmaceutical manufacturer against allegations of off-label promotion of drug; resulted in favorable $25 million settlement with DOJ.

Defended Fortune 50 healthcare conglomerate against off-label marketing, misbranding and kickback allegations regarding the drug Risperdal.

Conducted 14-month transnational external investigation of acquisition target (a major Norwegian oil and gas company) into potential FCPA violations, including reviewing all consulting agreements related to target company’s operations in 33 countries.

Conducted internal investigation of Fortune 200 pharmaceutical company as a result of its acquisition of a medical device company, focusing on potential FCPA in operations in Belarus, Russia and Libya; as a result, DOJ declined its official FCPA inquiry.

Conducted internal investigation of Fortune 100 multinational manufacturing conglomerate’s Turkish subsidiary concerning allegations of bid rigging, foreign bribery and other conduct; as a result of company’s significant cooperation throughout the investigation and compliance enhancement efforts, DOJ and SEC dropped their 4-year probe into the company.

Conducted internal investigation of medical devices manufacturer concerning potential FCPA violations in China and South Korea.

Conducted transnational internal FCPA-focused investigation for British medical implants manufacturer pursuant to SEC inquiry into its payments to government-employed physicians in Germany, Poland, Turkey and Greece.

Co-author, Managed Care Quarterly Review: Issue 1, McGuireWoods LLP, September 2017